Figure 1From: Prediction of kinase inhibitor response using activity profiling, in vitro screening, and elastic net regression Primary screen results of the top ten most selective kinase inhibitors. Drugs are ranked based on the IMR-90 to A549 viability ratio. The 3 digit codes identify the compounds: A15: PDK1/Akt1/Flt3 Dual Pathway Inhibitor (CAS 331253-86-2); E20: Cdk/Crk Inhibitor (CAS 784211-09-2); O20: SU9516 (CAS 666837-93-0); H15: MEK1/2 Inhibitor II (CAS 212631-61-3); L13: PI 3-Kα Inhibitor VIII (CAS 372196-77-5); G10: Fascaplysin, Synthetic (CAS 114719-57-2); D07: Cdk2 Inhibitor II (CAS 222035-13-4); C16: Cdk1/2 Inhibitor III (CAS 443798-55-8); M16: GSK3b Inhibitor XII, TWS119 (CAS 601514-19-6); N05: Reversine (CAS 656820-32-5). The chemical structure of these compounds is given in a Additional file 2.Back to article page